Tacrolimus treats ongoing allograft rejection by inhibiting interleukin-10 mediated functional cytotoxic cell infiltration. [electronic resource]
Producer: 20030306Description: 1378-81 p. digitalISSN:- 0041-1345
- Animals
- CD4-Positive T-Lymphocytes -- immunology
- CD8-Positive T-Lymphocytes -- immunology
- Cyclosporine -- therapeutic use
- Drug Therapy, Combination
- Graft Rejection -- prevention & control
- Granzymes
- Heart Transplantation -- immunology
- Immunosuppressive Agents -- therapeutic use
- Interleukin-10 -- antagonists & inhibitors
- Membrane Glycoproteins -- analysis
- Perforin
- Pore Forming Cytotoxic Proteins
- Rats
- Rats, Inbred BN
- Rats, Inbred Lew
- Serine Endopeptidases -- analysis
- Tacrolimus -- therapeutic use
- Transplantation, Homologous -- immunology
- Transplantation, Isogeneic -- immunology
No physical items for this record
Publication Type: Journal Article
There are no comments on this title.
Log in to your account to post a comment.